| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 156.472 | 130.456 | 127.784 | 145.661 | 144.451 | 150.527 | 144.845 | 146.406 | 145.321 | 155.761 |
| Total Income - EUR | 167.309 | 137.189 | 133.154 | 150.268 | 147.537 | 153.064 | 146.785 | 149.898 | 170.466 | 161.074 |
| Total Expenses - EUR | 173.148 | 145.417 | 143.938 | 142.857 | 140.941 | 144.151 | 143.147 | 149.990 | 148.887 | 166.608 |
| Gross Profit/Loss - EUR | -5.839 | -8.228 | -10.783 | 7.412 | 6.595 | 8.913 | 3.638 | -92 | 21.579 | -5.535 |
| Net Profit/Loss - EUR | -5.839 | -8.228 | -12.008 | 5.909 | 5.120 | 7.452 | 2.170 | -1.591 | 19.874 | -9.582 |
| Employees | 5 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Remedica 94 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.825 | 11.276 | 11.085 | 10.881 | 10.671 | 10.468 | 9.359 | 9.388 | 9.886 | 7.201 |
| Current Assets | 127.664 | 126.363 | 126.207 | 132.493 | 131.784 | 137.651 | 136.524 | 135.556 | 128.378 | 141.996 |
| Inventories | 41.312 | 40.065 | 39.859 | 40.728 | 42.837 | 49.798 | 50.985 | 56.138 | 56.552 | 60.519 |
| Receivables | 13.959 | 3.680 | 13.742 | 19.838 | 15.577 | 19.001 | 17.092 | 11.366 | 7.813 | 3.476 |
| Cash | 72.393 | 82.618 | 72.605 | 71.927 | 73.370 | 68.852 | 68.447 | 68.052 | 64.014 | 78.000 |
| Shareholders Funds | 69.395 | 60.459 | 47.428 | 52.466 | 56.570 | 62.950 | 63.757 | 62.364 | 82.049 | 72.009 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 70.094 | 77.180 | 89.863 | 90.909 | 85.885 | 85.169 | 82.125 | 82.580 | 56.215 | 77.189 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Remedica 94 Srl